GlassScriptPhysician profile
Miriam Tavakoly
NPI 1710247192
$3,529.19
in general payments reported to CMS, 2019-2025
16 companies · $1,054 in 2025
The $1,054 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.97 · 2022: $530 · 2023: $694 · 2024: $1,159 · 2025: $1,054.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,908.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,908.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $625.00 | 2022-2024 | Otezla, Repatha |
| Astrazeneca Pharmaceuticals LP | $621.10 | 2022-2025 | Breztri, Fasenra, Airsupra |
| Lilly USA, LLC | $416.06 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $412.19 | 2021-2025 | Jardiance |
| Genzyme Corporation | $400.00 | 2024-2025 | |
| Glaxosmithkline, LLC. | $228.35 | 2024-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Kowa Pharmaceuticals America, INC. | $183.72 | 2024-2025 | Zoryve |
| Teva Pharmaceuticals USA, INC. | $135.00 | 2023 | Austedo |
| Pfizer INC. | $134.65 | 2023-2025 | |
| Novo Nordisk INC | $125.00 | 2022 | |
| Intuity Medical INC | $113.02 | 2023 | Pogo Automatic Blood Glucose Monitoring System |
| Abbvie INC. | $42.48 | 2025 | |
| Eisai INC. | $31.71 | 2025 | |
| Kyowa Kirin, INC. | $27.15 | 2025 | |
| Amarin Pharma, INC. | $19.79 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $13.97 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miriam Tavakoly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.